KLRC1 and acute myeloid leukemia: demonstrated that CD57+ and KIR+ NK cells from healthy individuals exhibited the highest degree of cytotoxicity against AML blasts, while ALL targets were less susceptible to KIR+ NK subsets compared with NKG2A+ NK subsets (36).